White Counties Stand Apart: The Primacy of Residential Segregation in COVID-19 and HIV Diagnoses.


Journal

AIDS patient care and STDs
ISSN: 1557-7449
Titre abrégé: AIDS Patient Care STDS
Pays: United States
ID NLM: 9607225

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 25 8 2020
medline: 27 10 2020
entrez: 25 8 2020
Statut: ppublish

Résumé

Emerging epidemiological data suggest that white Americans have a lower risk of acquiring COVID-19. Although many studies have pointed to the role of systemic racism in COVID-19 racial/ethnic disparities, few studies have examined the contribution of racial segregation. Residential segregation is associated with differing health outcomes by race/ethnicity for various diseases, including HIV. This commentary documents differing HIV and COVID-19 outcomes and service delivery by race/ethnicity and the crucial role of racial segregation. Using publicly available Census data, we divide US counties into quintiles by percentage of non-Hispanic white residents and examine HIV diagnoses and COVID-19 per 100,000 population. HIV diagnoses decrease as the proportion of white residents increase across US counties. COVID-19 diagnoses follow a similar pattern: Counties with the highest proportion of white residents have the fewest cases of COVID-19 irrespective of geographic region or state political party inclination (i.e., red or blue states). Moreover, comparatively fewer COVID-19 diagnoses have occurred in primarily white counties throughout the duration of the US COVID-19 pandemic. Systemic drivers place racial minorities at greater risk for COVID-19 and HIV. Individual-level characteristics (e.g., underlying health conditions for COVID-19 or risk behavior for HIV) do not fully explain excess disease burden in racial minority communities. Corresponding interventions must use structural- and policy-level solutions to address racial and ethnic health disparities.

Identifiants

pubmed: 32833494
doi: 10.1089/apc.2020.0155
pmc: PMC7585613
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-424

Références

Lancet. 2012 Jul 28;380(9839):341-8
pubmed: 22819656
Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
JAMA Intern Med. 2015 Dec;175(12):1983-6
pubmed: 26437386
Am J Epidemiol. 2020 Oct 1;189(10):1065-1075
pubmed: 32219369
PLoS One. 2016 Mar 14;11(3):e0150410
pubmed: 26974165
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):366-370
pubmed: 32240126
AIDS Behav. 2014 Apr;18(4):776-82
pubmed: 24141487
AIDS Behav. 2018 Sep;22(9):3009-3023
pubmed: 29603112
Clin Infect Dis. 2012 Nov;55(9):1242-51
pubmed: 23019271
Am J Public Health. 2007 Jan;97(1):125-32
pubmed: 17138921
Health Aff (Millwood). 2015 Dec;34(12):2061-8
pubmed: 26643626
AIDS Educ Prev. 1993 Fall;5(3):196-211
pubmed: 8217472
Health Equity. 2019 Apr 08;3(1):99-108
pubmed: 31289768
Ann Epidemiol. 2020 Jul 23;:
pubmed: 32711053
J Community Health. 2011 Feb;36(1):141-9
pubmed: 20574776
MMWR Morb Mortal Wkly Rep. 2010 Jun 25;59(24):737-41
pubmed: 20577154
Health Aff (Millwood). 2005 Mar-Apr;24(2):325-34
pubmed: 15757915
Am J Public Health. 2020 Jul;110(7):1046-1053
pubmed: 32437270
Am J Public Health. 2018 Nov;108(S4):S246-S250
pubmed: 30383416
J Immigr Minor Health. 2007 Jan;9(1):49-54
pubmed: 17031578

Auteurs

Gregorio A Millett (GA)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Brian Honermann (B)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Austin Jones (A)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Elise Lankiewicz (E)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Jennifer Sherwood (J)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Susan Blumenthal (S)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Asal Sayas (A)

amfAR, Foundation for AIDS Research, Washington, District of Columbia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH